| Literature DB >> 28608797 |
Qiong Wang1,2, Feng Wang3, Zhenghong Xu4,5, Zhongyang Ding6,7.
Abstract
Mushrooms are widely distributed around the world and are heavily consumed because of their nutritional value and medicinal properties. Polysaccharides (PSs) are an important component of mushrooms, a major factor in their bioactive properties, and have been intensively studied during the past two decades. Monosaccharide composition/combinations are important determinants of PS bioactivities. This review summarizes: (i) monosaccharide composition/combinations in various mushroom PSs, and their relationships with PS bioactivities; (ii) possible biosynthetic pathways of mushroom PSs and effects of key enzymes on monosaccharide composition; (iii) regulation strategies in PS biosynthesis, and prospects for controllable biosynthesis of PSs with enhanced bioactivities.Entities:
Keywords: bioactivity; biosynthesis; monosaccharide composition; mushroom polysaccharides; regulation; structure-activity relationship
Mesh:
Substances:
Year: 2017 PMID: 28608797 PMCID: PMC6152739 DOI: 10.3390/molecules22060955
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Monosaccharide composition and molar ratio of polysaccharides from Ascomycetes.
| Species | Source | Monosaccharide Composition | Molar Ratio | Reference |
|---|---|---|---|---|
| mycelium | Man:Glc:Gal:GlcA | 9.6:4.0:4.4:1.0 | [ | |
| fruiting body | Man:Gal:Glc | 56.7:34.5:8.8 | [ | |
| NA | Man:Glc:Gal | 2.84:1:1.29 | [ | |
| Man:Glc:Gal | 2.05:1:1.09 | |||
| fruiting body | Man:Glc:Gal | 1:28.63:1.41 | [ | |
| Man:Glc:Gal | 1:12.41:0.74 | |||
| fruiting body | Man:Glc:Gal | 1.7:8.9:1 | [ | |
| NA | Glc:Rha:Xyl:Man:Ara:Gal | 63.10:39.11:20.12:15.16:2.05:0.12 | [ | |
| stroma | Fru:Man:Rha:GalN:Ara | 1.0:1.19:0.11:0.11:0.34 | [ | |
| Fru:Man:Rha:Glc:Ara | 1:1.29:0.14:0.07:0.32 | |||
| fruiting body | Xyl:Glc:Man:Rha:Gal | 5.4:5.0:6.5:7.8:72.3 | [ | |
| fruiting body | Glc:Man:Gal:Ara:Xyl:Rha | 38.06:14.43:17.06:9.25:2.08:0.94 | [ | |
| Glc:Man:Gal:Ara:Xyl:Rha | 27.04:28.66:11.12:9.07:6.71:3.22 | |||
| Glc:Man:Gal:Ara:Xyl:Rha | 24.69:20.46:10.22:7.91:4.05:2.83 | |||
| fermentation broth | Ara:Man:Glc:Gal | 0.7:2.8:24.8:1.0 | [ | |
| Rha:Man:Glc:Gal | 1.8:3.1:21.4:1.0 | |||
| fruiting body | Glc:Man:Gal | 60.56:20.12:19.32 | [ | |
| Glc | - | |||
| fruiting body | Glc:Gal:Fuc | 4:3:1 | [ |
Glc: glucose; Man: mannose; Gal: galactose, Xyl: xylose; Ara: arabinose, Rha: rhamnose, Fuc: fucose; GlcA: glucuronic acid; GalN: N-acetyl-galactosamine.
Monosaccharide composition and molar ratio of polysaccharides from Ganoderma species.
| Species | Source | Monosaccharide Composition | Molar Ratio | Reference |
|---|---|---|---|---|
| fruiting body | Rha:Ara:Xyl:Man:Glc:Gal | 11.4:30:27.1:8:9.1:14.3 | [ | |
| Rha:Ara:Xyl:Glc:Gal | 44.7:20.9:19.9:3.6:10.8 | |||
| NA | Man:Rha:Glc:Gal | 4.7:0.65:65.22:29.43 | [ | |
| fruiting body | Glc | - | [ | |
| Glc:Gal:Man | 29:1.8:1.0 | |||
| fruiting body | Glc | - | [ | |
| fermentation broth | Gal:Man:Glc:Ara:Rha | 103:17:12:10:3 | [ | |
| fruiting body | Glc:Fuc:Gal | 1.0:1.09:4.09 | [ | |
| fruiting body | Gal:Rha:Glc | 1.00:1.15:3.22 | [ | |
| fermented soybean curd residue | Ara:Rha:Xyl:Man:Glc | 4.66:1.23:3.1:0.61:1.29 | [ | |
| Ara:Xyl:Glc | 2.82:1.33:0.87 | |||
| Ara:Rha:Xyl:Gal:Man:Glc | 5.09:0.52:1.07:1.29:0.48:2.76 | |||
| fruiting body | Gal:Fuc:Glc | 75.87:11.83:6.02 | [ | |
| fruiting body | Glc:Man:Gal:GalA | 4.91:1:1.28:0.71 | [ | |
| fruiting body | Man:Glc:Gal | 4.7:27.1:1.0 | [ | |
| mycelium | Fuc:Xyl:Man:Gal:Glc:GlcNac | 2.9:16.1:66.7:9.4:0.1:4.3 | [ | |
| Fuc:Xyl:Man:Gal:Glc:GlcNac | 4.5:1.3:58.0:24.5:3.8:7.9 | |||
| fruiting body | Man:Gal:Glc:Ara:Fuc:Fru:Rha | 50.13:13.1:17.47:6.94:2.71:9.21:0.45 | [ | |
| Man:Gal:Glc:Ara:Fuc:Rha | 44.91:38.64:8.26:0.08:8.02:0.09 | |||
| Man:Gal:Glc:Ara:Fuc:Fru:Rha | 33.35:30.84:20.52:8.78:4.44:1.33:0.74 |
Glc: glucose; Man: mannose; Gal: galactose, Xyl: xylose; Ara: arabinose, Rha: rhamnose, Fuc: fucose; GalA: galacturonic acid; GlcNac: N-acetyl-glucosamine.
Biological activities of active components in mushroom PSs.
| Species | Biological Activity | Active Component | Reference |
|---|---|---|---|
| antioxidant and anticancer activity | Man | [ | |
| cytokine-stimulating activity | Man | [ | |
| antioxidant activity | Rha | [ | |
| antioxidant activity | Rha | [ | |
| antioxidant activity | Glc, Gal | [ | |
| macrophage activation | Man, Rha | [ | |
| antioxidant activity | Man, Rha, Xyl | [ | |
| antioxidant activity | Man, Glc | [ | |
| antioxidant activity | Man, Rha, GalA | [ |
Figure 1Proposed/deduced/hypothesized biosynthetic pathways for mushroom PSs. 1. Glucokinase (GK); 2. Phosphoglucose isomerase (PGI); 3. Fructose-1,6-biphosphatase (FBPase); 4. Phosphofructokinase (FPK); 5. Phosphomannose isomerase (PMI); 6. Phosphomannose mutase (PMM); 7. GDP-Man pyrophosphorylase (GMP); 8. GDP-Man dehydratase (GMD); 9. GDP-4-keto-6-deoxymannose epimerase/reductase (GMER); 10. Phosphoglucose mutase (PGM); 11. dTDP-glucose pyrophosphorlase (dTDP-GPP); 12 and 13. dTDP-Rha synthase (dTRS); 14. UDP-Glc pyrophosphorylase (UGP); 15. UDP-Gal-4-epimerase (UGE); 16. UDP-Glc dehydrogenase (UGDG). 17. UDP-glucuronate decarboxylase/UDP-Xyl synthase (UXS); 18. UDP-Xyl-4-epimerase (UXE).
Figure 2Correlations (R2) between activities of exopolysaccharide (EPS) synthesis enzymes and monosaccharide mole percentages under various carbon source conditions. (A) Phosphoglucose isomerase (PGI) and Man; (B) Phosphomannose isomerase (PMI) and Man; (C) GDP-Man pyrophosphorylase (GMP) and Man; (D) Phosphoglucose mutase (PGM) and Gal.